LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants

被引：7

作者：

Westendorf, Kathryn ^{[1
]}

Zentelis, Stefanie ^{[1
]}

Wang, Lingshu ^{[2
]}

Foster, Denisa ^{[3
]}

Vaillancourt, Peter ^{[3
]}

Wiggin, Matthew ^{[1
]}

Lovett, Erica ^{[1
]}

van der Lee, Robin ^{[1
]}

Hendle, Joerg ^{[3
]}

Pustilnik, Anna ^{[3
]}

Sauder, J. Michael ^{[3
]}

Kraft, Lucas ^{[1
]}

Hwang, Yuri ^{[1
]}

Siegel, Robert W. ^{[4
]}

Chen, Jinbiao ^{[4
]}

Heinz, Beverly A. ^{[4
]}

Higgs, Richard E. ^{[4
]}

Kallewaard, Nicole L. ^{[4
]}

Jepson, Kevin ^{[1
]}

Goya, Rodrigo ^{[1
]}

Smith, Maia A. ^{[1
]}

Collins, David W. ^{[1
]}

Pellacani, Davide ^{[1
]}

Xiang, Ping ^{[1
]}

de Puyraimond, Valentine ^{[1
]}

Ricicova, Marketa ^{[1
]}

Devorkin, Lindsay ^{[1
]}

Pritchard, Caitlin ^{[1
]}

O'Neill, Aoise ^{[1
]}

Dalal, Kush ^{[1
]}

Panwar, Pankaj ^{[1
]}

Dhupar, Harveer ^{[1
]}

Garces, Fabian A. ^{[1
]}

Cohen, Courtney A. ^{[5
]}

Dye, John M. ^{[5
]}

Huie, Kathleen E. ^{[5
]}

V. Badger, Catherine ^{[5
]}

Kobasa, Darwyn ^{[6
,7
]}

Audet, Jonathan ^{[6
,7
]}

Freitas, Joshua J. ^{[3
]}

Hassanali, Saleema ^{[3
]}

Hughes, Ina ^{[3
]}

Munoz, Luis ^{[3
]}

Palma, Holly C. ^{[3
]}

Ramamurthy, Bharathi ^{[3
]}

Cross, Robert W. ^{[7
,8
,9
]}

Geisbert, Thomas W. ^{[7
,8
,9
]}

Menachery, Vineet ^{[8
,9
]}

Lokugamage, Kumari ^{[8
,9
]}

Borisevich, Viktoriya ^{[8
]}

机构：

[1] AbCellera Biol Inc, Vancouver, BC V5Y 0A1, Canada

[2] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA

[3] Eli Lilly & Co, Lilly Biotechnol Ctr, San Diego, CA 92121 USA

[4] Eli Lilly & Co, Indianapolis, IN 46285 USA

[5] US Army Med Res Inst Infect Dis USAMRIID, Frederick, MD 21702 USA

[6] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB R3E 3L5, Canada

[7] Univ Manitoba, Winnipeg, MB R3T 2N2, Canada

[8] Univ Texas Med Branch, Galveston Natl Lab, Galveston, TX 77555 USA

[9] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA

来源：

CELL REPORTS | 2022年 / 39卷 / 07期

基金：

欧盟地平线“2020”;

关键词：

VALIDATION; IMMUNITY;

D O I：

10.1016/j.celrep.2022.110812

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-neutralizing monoclonal antibodies (mAbs) can reduce the risk of hospitalization from coronavirus disease 2019 (COVID-19) when administered early. However, SARS-CoV-2 variants of concern (VOCs) have negatively affected therapeutic use of some authorized mAbs. Using a high-throughput B cell screening pipeline, we isolated LY-CoV1404 (bebtelovimab), a highly potent SARS-CoV-2 spike glycoprotein receptor binding domain (RBD)-specific antibody. LYCoV1404 potently neutralizes authentic SARS-CoV-2, B.1.1.7, B.1.351, and B.1.617.2. In pseudovirus neutralization studies, LY-CoV1404 potently neutralizes variants, including B.1.1.7, B.1.351, B.1.617.2, B.1.427/ B.1.429, P.1, B.1.526, B.1.1.529, and the BA.2 subvariant. Structural analysis reveals that the contact residues of the LY-CoV1404 epitope are highly conserved, except for N439 and N501. The binding and neutralizing activity of LY-CoV1404 is unaffected by the most common mutations at these positions (N439K and N501Y). The broad and potent neutralization activity and the relatively conserved epitope suggest that LY-CoV1404 has the potential to be an effective therapeutic agent to treat all known variants.

引用

页数：26

共 50 条

[1] Concerns on Bebtelovimab (LY-CoV1404) used to neutralize Omicron subvariants
Wang, Xuejun
Yang, Yang
Song, Zhifei
Wang, Yiming
Yang, Peng
Li, Xinyu
Wang, Fei
Wang, Mingming
Shao, Liting
Wang, Shengqi
JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (02)
[2] Concerns on Bebtelovimab (LY-CoV1404) used to neutralize Omicron subvariants Reply
Abd-Elsalam, Sherief
Medhat, Mohammed A.
Ramadan, Haidi Karam-Allah
Soliman, Shaimaa
JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (02)
[3] A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses
Wang, Pengfei
Casner, Ryan G.
Nair, Manoj S.
Yu, Jian
Guo, Yicheng
Wang, Maple
Chan, Jasper F-W
Cerutti, Gabriele
Iketani, Sho
Liu, Lihong
Sheng, Zizhang
Chen, Zhiwei
Yuen, Kwok-Yung
Kwong, Peter D.
Huang, Yaoxing
Shapiro, Lawrence
Ho, David D.
EMERGING MICROBES & INFECTIONS, 2022, 11 (01) : 147 - 157
[4] A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2 Omicron and Other Variants of Concern
Yuan, Mengqi
Chen, Xiangyu
Zhu, Yanzhi
Dong, Xiaoqing
Liu, Yan
Qian, Zhaohui
Ye, Lilin
Liu, Pinghuang
JOURNAL OF VIROLOGY, 2022, 96 (16)
[5] SARS-CoV-2 variants and bebtelovimab: immune escape mechanisms revealed by computational studies
Roy, Rakesh Kumar
Sharma, Madhur
Patra, Niladri
PHYSICAL CHEMISTRY CHEMICAL PHYSICS, 2024, 26 (48) : 29929 - 29939
[6] Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice
De Gasparo, Raoul
Pedotti, Mattia
Simonelli, Luca
Nickl, Petr
Muecksch, Frauke
Cassaniti, Irene
Percivalle, Elena
Lorenzi, Julio C. C.
Mazzola, Federica
Magri, Davide
Michalcikova, Tereza
Haviernik, Jan
Honig, Vaclav
Mrazkova, Blanka
Polakova, Natalie
Fortova, Andrea
Tureckova, Jolana
Iatsiuk, Veronika
Di Girolamo, Salvatore
Palus, Martin
Zudova, Dagmar
Bednar, Petr
Bukova, Ivana
Bianchini, Filippo
Mehn, Dora
Nencka, Radim
Strakova, Petra
Pavlis, Oto
Rozman, Jan
Gioria, Sabrina
Sammartino, Jose Camilla
Giardina, Federica
Gaiarsa, Stefano
Pan-Hammarstrom, Qiang
Barnes, Christopher O.
Bjorkman, Pamela J.
Calzolai, Luigi
Piralla, Antonio
Baldanti, Fausto
Nussenzweig, Michel C.
Bieniasz, Paul D.
Hatziioannou, Theodora
Prochazka, Jan
Sedlacek, Radislav
Robbiani, Davide F.
Ruzek, Daniel
Varani, Luca
NATURE, 2021, 593 (7859) : 424 - +
[7] Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice
Raoul De Gasparo
Mattia Pedotti
Luca Simonelli
Petr Nickl
Frauke Muecksch
Irene Cassaniti
Elena Percivalle
Julio C. C. Lorenzi
Federica Mazzola
Davide Magrì
Tereza Michalcikova
Jan Haviernik
Vaclav Honig
Blanka Mrazkova
Natalie Polakova
Andrea Fortova
Jolana Tureckova
Veronika Iatsiuk
Salvatore Di Girolamo
Martin Palus
Dagmar Zudova
Petr Bednar
Ivana Bukova
Filippo Bianchini
Dora Mehn
Radim Nencka
Petra Strakova
Oto Pavlis
Jan Rozman
Sabrina Gioria
Josè Camilla Sammartino
Federica Giardina
Stefano Gaiarsa
Qiang Pan-Hammarström
Christopher O. Barnes
Pamela J. Bjorkman
Luigi Calzolai
Antonio Piralla
Fausto Baldanti
Michel C. Nussenzweig
Paul D. Bieniasz
Theodora Hatziioannou
Jan Prochazka
Radislav Sedlacek
Davide F. Robbiani
Daniel Ruzek
Luca Varani
Nature, 2021, 593 : 424 - 428
[8] A potent alpaca-derived nanobody that neutralizes SARS-CoV-2 variants
Weinstein, Jules B.
Bates, Timothy A.
Leier, Hans C.
McBride, Savannah K.
Barklis, Eric
Tafesse, Fikadu G.
ISCIENCE, 2022, 25 (03)
[9] VARIANTS OF SARS-COV-2
Krzywinski, Martin
AMERICAN SCIENTIST, 2022, 110 (02) : 76 - 76
[10] On the SARS-CoV-2 Variants
Scarpa, Fabio
Branda, Francesco
Petrosillo, Nicola
Ciccozzi, Massimo
INFECTIOUS DISEASE REPORTS, 2024, 16 (02) : 289 - 297

← 1 2 3 4 5 →